Skip to main content
Fig. 4 | Radiation Oncology

Fig. 4

From: High-volume prostate biopsy core involvement is not associated with an increased risk of cancer recurrence following 5-fraction stereotactic body radiation therapy monotherapy

Fig. 4

A Biochemical progression free survival stratified by < 50% and ≥ 50% biopsy core involvement for overall cohort. B Biochemical progression free survival stratified by < 50% and ≥ 50% biopsy core involvement for low risk cohort. C Biochemical progression free survival stratified by < 50% and ≥ 50% biopsy core involvement for intermediate cohort. D Biochemical progression free survival stratified by < 50% and ≥ 50% biopsy core involvement for high risk cohort

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us